Literature DB >> 26551920

Negotiating the use of female-initiated HIV prevention methods in a context of gender-based violence: the narrative of rape.

Miriam Hartmann1, Elizabeth Montgomery1, Jonathan Stadler2, Nicole Laborde1, Busisiwe Magazi2, Florence Mathebula2, Ariane van der Straten1,3.   

Abstract

Female-initiated methods of HIV prevention are needed to address barriers to HIV prevention rooted in gender inequalities. Understanding the sociocultural context of pre-exposure prophylaxis (PrEP) trials, including gender-based violence, is thus critical. MTN-003C (VOICE-C), a qualitative sub-study of the larger MTN-003 (VOICE) trial, examined sociocultural barriers and facilitators to PrEP amongst women in Johannesburg. We conducted focus-group discussions, in-depth interviews and ethnographic interviews with 102 trial participants, 22 male partners, 17 community advisory board members and 23 community stakeholders. We analysed how discussions of rape are emblematic of the gendered context in which HIV risk occurs. Rape emerged spontaneously in half of discussions with community advisory board members, two-thirds with stakeholders and among one-fifth of interviews/discussions with trial participants. Rape was used to reframe HIV risk as external to women's or partner's behaviour and to justify the importance of PrEP. Our research illustrates how women, in contexts of high levels of sexual violence, may use existing gender inequalities to negotiate PrEP use. This suggests that future interventions should simultaneously address harmful gender attitudes, as well as equip women with alternative means to negotiate product use, in order to more effectively empower women to protect themselves from HIV.

Entities:  

Keywords:  Gender; HIV prevention; South Africa; female-initiated methods; pre-exposure prophylaxis; sexual violence

Mesh:

Substances:

Year:  2015        PMID: 26551920      PMCID: PMC4845669          DOI: 10.1080/13691058.2015.1101786

Source DB:  PubMed          Journal:  Cult Health Sex        ISSN: 1369-1058


  29 in total

1.  High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women.

Authors:  A van der Straten; E T Montgomery; H Cheng; L Wegner; G Masenga; C von Mollendorf; L Bekker; S Ganesh; K Young; J Romano; A Nel; C Woodsong
Journal:  AIDS Behav       Date:  2012-10

2.  Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study.

Authors:  Rachel K Jewkes; Kristin Dunkle; Mzikazi Nduna; Nwabisa Shai
Journal:  Lancet       Date:  2010-07-03       Impact factor: 79.321

3.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.

Authors:  Jeanne M Marrazzo; Gita Ramjee; Barbra A Richardson; Kailazarid Gomez; Nyaradzo Mgodi; Gonasagrie Nair; Thesla Palanee; Clemensia Nakabiito; Ariane van der Straten; Lisa Noguchi; Craig W Hendrix; James Y Dai; Shayhana Ganesh; Baningi Mkhize; Marthinette Taljaard; Urvi M Parikh; Jeanna Piper; Benoît Mâsse; Cynthia Grossman; James Rooney; Jill L Schwartz; Heather Watts; Mark A Marzinke; Sharon L Hillier; Ian M McGowan; Z Mike Chirenje
Journal:  N Engl J Med       Date:  2015-02-05       Impact factor: 91.245

4.  Concerns about partner infidelity are a barrier to adoption of HIV-prevention strategies among young South African couples.

Authors:  Lisa Parker; Audrey Pettifor; Suzanne Maman; Jabu Sibeko; Catherine MacPhail
Journal:  Cult Health Sex       Date:  2014-05-12

5.  Intimate partner violence and condom and diaphragm nonadherence among women in an HIV prevention trial in southern Africa.

Authors:  Deborah Kacanek; Alan Bostrom; Elizabeth T Montgomery; Gita Ramjee; Guy de Bruyn; Kelly Blanchard; Amelia Rock; Sibongile Mtetwa; Ariane van der Straten
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-01       Impact factor: 3.731

6.  Hidden harms: women's narratives of intimate partner violence in a microbicide trial, South Africa.

Authors:  Jonathan Stadler; Sinead Delany-Moretlwe; Thesla Palanee; Helen Rees
Journal:  Soc Sci Med       Date:  2014-03-22       Impact factor: 4.634

7.  The importance of male partner involvement for women's acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe.

Authors:  Elizabeth T Montgomery; Ariane van der Straten; Agnes Chidanyika; Tsungai Chipato; Shabbar Jaffar; Nancy Padian
Journal:  AIDS Behav       Date:  2011-07

8.  Gender inequitable masculinity and sexual entitlement in rape perpetration South Africa: findings of a cross-sectional study.

Authors:  Rachel Jewkes; Yandisa Sikweyiya; Robert Morrell; Kristin Dunkle
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

9.  Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.

Authors:  Ariane van der Straten; Jonathan Stadler; Elizabeth Montgomery; Miriam Hartmann; Busiswe Magazi; Florence Mathebula; Katie Schwartz; Nicole Laborde; Lydia Soto-Torres
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

Review 10.  An evidence review of gender-integrated interventions in reproductive and maternal-child health.

Authors:  Joan Marie Kraft; Karin Gwinn Wilkins; Guiliana J Morales; Monique Widyono; Susan E Middlestadt
Journal:  J Health Commun       Date:  2014
View more
  2 in total

1.  Acceptability and feasibility of the CHARISMA counseling intervention to support women's use of pre-exposure prophylaxis: results of a pilot study.

Authors:  Ellen K Wilson; L Danielle Wagner; Thesla Palanee-Phillips; Sarah T Roberts; Elizabeth E Tolley; Florence Mathebula; Laura Pascoe; Michele Lanham; Rose Wilcher; Elizabeth T Montgomery
Journal:  BMC Womens Health       Date:  2021-03-25       Impact factor: 2.809

2.  Forming and implementing community advisory boards in low- and middle-income countries: a scoping review.

Authors:  Yang Zhao; Thomas Fitzpatrick; Bin Wan; Suzanne Day; Allison Mathews; Joseph D Tucker
Journal:  BMC Med Ethics       Date:  2019-10-17       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.